{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:53:05Z","timestamp":1790257985271,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI15C2221"],"award-info":[{"award-number":["HI15C2221"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jconrel.2016.01.046","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T17:46:37Z","timestamp":1453916797000},"page":"301-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"special_numbering":"C","title":["Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors"],"prefix":"10.1016","volume":"225","author":[{"given":"Hyeong Jun","family":"Byeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Quang","family":"Thao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Gon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9099-9230","authenticated-orcid":false,"given":"Yu Seok","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.01.046_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.apsb.2014.03.001","article-title":"Brain tumor-targeted drug delivery strategies","volume":"4","author":"Wei","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14","author":"Dolecek","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.addr.2011.11.014","article-title":"Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents","volume":"64","author":"Biddlestone-Thorpe","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","article-title":"Drug targeting to the brain","volume":"47","author":"de Boer","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0030","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-010-0141-7","article-title":"Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jconrel.2005.03.027","article-title":"Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery","volume":"107","author":"Lu","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1570159X11311020006","article-title":"Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system","volume":"11","author":"Zou","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","article-title":"Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0055","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1016\/j.biomaterials.2013.08.030","article-title":"Choline transporter-targeting and co-delivery system for glioma therapy","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.01.025","article-title":"Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome","volume":"444","author":"Lv","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0065","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1016\/j.biomaterials.2013.08.039","article-title":"LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0070","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1016\/j.biomaterials.2012.03.058","article-title":"Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles","volume":"33","author":"Gao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/02656739509022457","article-title":"Extracellular pH distribution in human tumours","volume":"11","author":"Engin","year":"1995","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0090","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","article-title":"Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel","volume":"12","author":"Desai","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.10.041","article-title":"Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity","volume":"403","author":"Kim","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jps.22298","article-title":"Preparation and characterization of Apo2L\/TNF-related apoptosis-inducing ligand-loaded human serum albumin nanoparticles with improved stability and tumor distribution","volume":"100","author":"Kim","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0105","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.biomaterials.2011.10.050","article-title":"Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types","volume":"33","author":"Bae","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2014.11.008","article-title":"Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer","volume":"197","author":"Choi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0115","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02652048.2011.590614","article-title":"Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo","volume":"28","author":"Zhang","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0120","first-page":"150","article-title":"Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2008.05.039","article-title":"Development and evaluation of novel itraconazole-loaded intravenous nanoparticles","volume":"362","author":"Chen","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actbio.2013.08.046","article-title":"Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer","volume":"10","author":"Byeon","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0135","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.biomaterials.2012.04.018","article-title":"Doxorubicin-loaded highly porous large PLGA microparticles as a sustained-release inhalation system for the treatment of metastatic lung cancer","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0140","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1016\/j.biomaterials.2013.05.018","article-title":"Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7007-10-29","article-title":"Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation","volume":"10","author":"Vinci","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0155","first-page":"709","article-title":"Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238","volume":"6","author":"Kiaris","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0160","first-page":"45","article-title":"Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features","volume":"27","author":"Takagi","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7812\/TPP\/08-027","article-title":"Prognostic factors for long-term survival after glioblastoma","volume":"12","author":"Walid","year":"2008","journal-title":"Perm. J."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0175","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1021\/jm020276c","article-title":"Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound","volume":"45","author":"Kratz","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2014.03.006","article-title":"The role of glucose transporters in the distribution of p-aminophenyl-alpha-d-mannopyranoside modified liposomes within mice brain","volume":"182","author":"Du","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herve","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2006.11.015","article-title":"Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle","volume":"118","author":"Lu","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2009.09.020","article-title":"Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals","volume":"141","author":"Ying","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0200","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.biomaterials.2012.02.004","article-title":"A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/humrep\/16.6.1229","article-title":"Facilitated glucose transporters play a crucial role throughout mouse preimplantation embryo development","volume":"16","author":"Leppens-Luisier","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0210","first-page":"3421","article-title":"Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes","volume":"7","author":"Pang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.046_bb0215","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/JVI.78.8.4120-4133.2004","article-title":"CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor","volume":"78","author":"Liu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.01.046_bb0220","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","article-title":"Glioma targeting and blood\u2013brain barrier penetration by dual-targeting doxorubincin liposomes","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916300426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916300426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T20:07:27Z","timestamp":1556309247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916300426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":44,"alternative-id":["S0168365916300426"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.046","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}